TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $275,000 | -35.0% | 2,800 | -34.6% | 0.00% | -33.3% |
Q1 2018 | $423,000 | -8.2% | 4,281 | -2.7% | 0.00% | -25.0% |
Q4 2017 | $461,000 | -90.1% | 4,400 | -86.3% | 0.00% | -88.2% |
Q2 2016 | $4,668,000 | +41.1% | 32,059 | +38.8% | 0.03% | +6.2% |
Q1 2016 | $3,309,000 | +125.4% | 23,102 | +143.2% | 0.03% | +146.2% |
Q4 2015 | $1,468,000 | +76.2% | 9,500 | +62.9% | 0.01% | +62.5% |
Q3 2015 | $833,000 | -41.5% | 5,832 | -41.1% | 0.01% | -42.9% |
Q2 2015 | $1,423,000 | -38.5% | 9,900 | -39.6% | 0.01% | -36.4% |
Q1 2015 | $2,313,000 | – | 16,400 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
Think Investments LP | 186,373 | $28,804,000 | 8.16% |
Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |